Melanoscan LLC

Melanoscan is a verified, patented full-body digital imaging system for early melanoma detection, addressing a genuine medical need. However, the submission contains severely exaggerated claims of traction ('most people have used my product'), confusing financial metrics, and overall low response quality. While the underlying technology has clinical relevance, the lack of verifiable consumer scale and poor submission details result in heavy penalties across reach, traction, and response metrics, placing it in the minimal traction category.